Matthew Johnson

Matthew Johnson is a seasoned professional with extensive experience in clinical science and research, currently serving as the Senior Director of Clinical Science at Dexcom since October 2015. Responsibilities include overseeing global clinical science activities and directing clinical science initiatives for product development, particularly in type 2 diabetes. Prior roles at Dexcom involved building teams for clinical research and supporting new product launches. Previously, Matthew held academic positions at Mayo Clinic, contributing to research on artificial pancreas systems and clinical trial management. Other consulting roles spanned regulatory guidance and clinical trials. Matthew holds a BS and Ph.D. in Nutrition and Toxicology and Integrative Biology from the University of California, Berkeley.